ERICA BELLO-RODRIGUEZ: Open Payments
NPI 1831702422 · SLEEPY HOLLOW, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,263 in 16 payments from 7 companies in 2025. Trend: 2023 $252 · 2024 $689 · 2025 $1,263
Food & beverage: $1,264
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $477 |
| ABBVIE INC. | 7 | $168 |
| GENZYME CORPORATION | 1 | $125 |
| Kite Pharma, Inc. | 1 | $125 |
| Janssen Biotech, Inc. | 1 | $125 |
| E.R. Squibb & Sons, L.L.C. | 1 | $122 |
| Exelixis Inc. | 1 | $122 |
Products named: LYNPARZA, SARCLISA, DATROWAY, RYBREVANT, REBLOZYL, CABOMETYX, EPKINLY, VENCLEXTA.
Industry payments across NY — which companies pay providers there.
